Shrinking lung syndrome associated with systemic lupus erythematosus: A multicenter collaborative study of 15 new cases and a review of the 155 cases in the literature focusing on treatment response and long-term outcomes
Loïc Duron(Inserm), Zahir Amoura(Inserm), Olivier Vittecoq(Centre Hospitalier Universitaire de Rouen), Christophe Richez(Centre National de la Recherche Scientifique), S. Abad(Université Sorbonne Paris Nord), Raphaël Borie(Inserm), David Saadoun(Sorbonne Université), Julien Haroche(Inserm), Élisabeth Diot(Centre Hospitalier Universitaire de Tours), Christopher Banse(Inserm), Fleur Cohen‐Aubart(Inserm)
Cited by 73
Related Papers
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501